Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nora Langreder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Affinity and Stability Maturation by Error-Prone PCRNora Langreder, Dorina Schäckermann, Tobias Unkauf, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Selection in Solution Using Magnetic BeadsPhilip Alexander Heine, Maximilian Ruschig, Nora Langreder, et al.
Biological Chemistry|March 21, 2022
<i>In vitro</i> evolution of <i>myc-</i>tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-MycGiulio Russo, Tobias Unkauf, Doris Meier, et al.
Scientific Reports|March 10, 2023
Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horsesNora Langreder, Dorina Schäckermann, Doris Meier, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Selection via Phage Display in Microtiter PlatesStephan Steinke, Kristian Daniel Ralph Roth, Maximilian Ruschig, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Affinity and Stability Maturation by Error-Prone PCRNora Langreder, Dorina Schäckermann, Tobias Unkauf, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Selection in Solution Using Magnetic BeadsPhilip Alexander Heine, Maximilian Ruschig, Nora Langreder, et al.
Biological Chemistry|March 21, 2022
<i>In vitro</i> evolution of <i>myc-</i>tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-MycGiulio Russo, Tobias Unkauf, Doris Meier, et al.
Scientific Reports|March 10, 2023
Development of an inhibiting antibody against equine interleukin 5 to treat insect bite hypersensitivity of horsesNora Langreder, Dorina Schäckermann, Doris Meier, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Antibody Selection via Phage Display in Microtiter PlatesStephan Steinke, Kristian Daniel Ralph Roth, Maximilian Ruschig, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 7, 2023
Mapping Epitopes by Phage DisplayStephan Steinke, Kristian Daniel Ralph Roth, Ruben Englick, et al.
Scientific Reports|December 8, 2020
Baculovirus-free insect cell expression system for high yield antibody and antigen productionJanin Korn, Dorina Schäckermann, Toni Kirmann, et al.
Frontiers in Cellular and Infection Microbiology|July 26, 2021
Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and TherapyKristian Daniel Ralph Roth, Esther Veronika Wenzel, Maximilian Ruschig, et al.
Nature Communications|March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interfaceFederico Bertoglio, Doris Meier, Nora Langreder, et al.
Cell Reports|July 17, 2021
A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutationsFederico Bertoglio, Viola Fühner, Maximilian Ruschig, et al.
Pageof 1